# 20/20 Biolabs, Inc.: Form 8-K, filed May 20, 2026

- Company: [20/20 Biolabs, Inc.](/companies/aidx.md) (CIK 1139685)
- Form: 8-K
- Filed: 2026-05-20
- Accepted by EDGAR: May 20, 2026, 20:10 ET
- Period: 2026-05-20
- Accession: 0001213900-26-059526
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1139685/000121390026059526/ea0291642-8k_2020bio.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1139685/000121390026059526/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1139685/000121390026059526/ea0291642-8k_2020bio.htm

Filed May 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-059526. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.